EP2961383
SUSPENSION FOR ORAL ADMINISTRATION COMPRISING AMORPHOUS TOLVAPTAN
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
28.2.2014EP published:
27.2.2019EP application number:
14712793.0
EPO information:
European Patent Register
Max expiry date:
27.2.2034
Title:
SUSPENSION FOR ORAL ADMINISTRATION COMPRISING AMORPHOUS TOLVAPTAN
Timeline
Today
28.2.2014EP application
27.2.2019EP Publication
Owner
Name:
Otsuka Pharmaceutical Co., Ltd.Address:
9, Kanda-Tsukasamachi 2-chome Chiyoda-ku, 101-8535, Tokyo, JP
Inventor
Name:
AKAGI, AkitsunaAddress:
Osaka-shiOsaka, JP
Name:
SUZUKI, KaiAddress:
Osaka-shiOsaka, JP
Name:
NAKAMURA, AtsuyaAddress:
Osaka-shiOsaka, JP
Name:
NISHIBAYASHI, ToruAddress:
Osaka-shiOsaka, JP
Priority
Number:
2013041105Date:
1.3.2013Country:
JP
Classification
Categories:
A61K 9/08, A61K 47/26, A61K 47/38, A61K 9/16, A61K 31/55